<< Revenir à la page d'accueil
13th november 2012
Maison de la Chimie, Paris
Genomic of hepatocellular tumors: from gene mutations to targeted therapies
Jessica ZUCMAN ROSSI
Inserm - Université Paris Descartes - Hôpital Saint-Louis, Paris
⤢
Genomic of hepatocellular tumors: from gene mutations to targeted therapies
Cancer is a disease of the genome
Genomic approaches in liver tumors: 3 major aims
Hepatocellular carcinoma: exome sequencing
ICGC Goal
Five major pathways altered in HCC
High genomic diversity in hepatocellular carcinoma revealed by next-generation sequencing
Post-genomic functional validation in hepatocellular carcinoma
Functional validation of a new tumor supressor genes: IRF2
Modeling IRF2 silencing to identify targets for drugs
Post-genomic clinical applications in hepatocellular carcinoma
Post-genomic clinical applications: prognosis prediction in HCC
Perspectives
Thanks
|«
«
▶||
»
»|
0:00:00